Filing Details
- Accession Number:
- 0001179110-17-011785
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-23 18:04:52
- Reporting Period:
- 2017-08-21
- Accepted Time:
- 2017-08-23 17:04:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1583107 | Theravance Biopharma Inc. | TBPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1597334 | Frank Pasqualone | C/O Theravance Biopharma Us, Inc. 901 Gateway Blvd South San Francisco CA 94080 | Svp, Chief Comm Ops Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2017-08-21 | 4,000 | $26.34 | 213,180 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Represents the weighted average purchase price per share for the open market purchase on August 21, 2017. The shares were purchased at prices ranging from $26.2499 to $26.4541 per share. Full information regarding the number of shares purchased at each price shall be provided upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Billionaire Hedge Funds
